blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3681448

EP3681448 - DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.09.2024
Database last updated on 30.10.2024
FormerThe patent has been granted
Status updated on  29.09.2023
FormerGrant of patent is intended
Status updated on  14.05.2023
FormerExamination is in progress
Status updated on  15.09.2022
FormerRequest for examination was made
Status updated on  19.06.2020
FormerThe international publication has been made
Status updated on  22.03.2019
Formerunknown
Status updated on  13.10.2018
Most recent event   Tooltip06.09.2024No opposition filed within time limitpublished on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
[2020/30]
Inventor(s)01 / BOSCHETTI, Federica
c/o Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
02 / FERRONI, Marco
c/o Technology Transfer Office (TTO)
Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
03 / CEREDA, Matteo Giuseppe
c/o Technology Transfer Office (TTO)
Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
 [2020/42]
Former [2020/30]01 / BOSCHETTI, Federica
c/o Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
02 / FERRONI, Marco
c/o Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
03 / CEREDA, Matteo Giuseppe
c/o Politecnico di Milano
Piazza Leonardo da Vinci 32
20133 Milano / IT
Representative(s)Rigamonti, Dorotea, et al
Marchi & Partners S.r.l.
Via Vittorio Pisani, 13
20124 Milano / IT
[N/P]
Former [2020/30]Rigamonti, Dorotea, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
Application number, filing date18780237.611.09.2018
[2020/30]
WO2018IB56907
Priority number, dateIT2017010158212.09.2017         Original published format: IT201700101582
[2020/30]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019053584
Date:21.03.2019
Language:EN
[2019/12]
Type: A1 Application with search report 
No.:EP3681448
Date:22.07.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 21.03.2019 takes the place of the publication of the European patent application.
[2020/30]
Type: B1 Patent specification 
No.:EP3681448
Date:01.11.2023
Language:EN
[2023/44]
Search report(s)International search report - published on:EP21.03.2019
ClassificationIPC:A61F9/00, A61K9/00, A61K47/02, A61P27/00
[2023/22]
CPC:
A61F9/0017 (EP,US); A61K47/02 (EP,US); A61K9/0051 (EP,US);
A61P27/00 (EP); A61F2210/0004 (EP); A61F2240/001 (US);
A61F2250/0068 (EP,US) (-)
Former IPC [2020/30]A61F9/00, A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/30]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VORRICHTUNG ZUR INTRAOKULAREN FREISETZUNG EINES ARZNEIMITTELS[2020/30]
English:DEVICE FOR INTRAOCULAR RELEASE OF A MEDICAMENT[2020/30]
French:DISPOSITIF D'ADMINISTRATION INTRAOCULAIRE DE MÉDICAMENT[2020/30]
Entry into regional phase03.04.2020National basic fee paid 
03.04.2020Designation fee(s) paid 
03.04.2020Examination fee paid 
Examination procedure03.04.2020Amendment by applicant (claims and/or description)
03.04.2020Examination requested  [2020/30]
03.04.2020Date on which the examining division has become responsible
14.09.2022Despatch of a communication from the examining division (Time limit: M04)
13.01.2023Reply to a communication from the examining division
15.05.2023Communication of intention to grant the patent
08.09.2023Fee for grant paid
08.09.2023Fee for publishing/printing paid
08.09.2023Receipt of the translation of the claim(s)
Opposition(s)02.08.2024No opposition filed within time limit [2024/41]
Fees paidRenewal fee
28.09.2020Renewal fee patent year 03
29.09.2021Renewal fee patent year 04
21.09.2022Renewal fee patent year 05
21.09.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT01.11.2023
CZ01.11.2023
DK01.11.2023
EE01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SK01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
[2024/36]
Former [2024/35]AT01.11.2023
CZ01.11.2023
DK01.11.2023
EE01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/34]AT01.11.2023
DK01.11.2023
EE01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/33]AT01.11.2023
DK01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
SM01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/26]AT01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
LV01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/25]AT01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
NL01.11.2023
PL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/24]AT01.11.2023
ES01.11.2023
HR01.11.2023
LT01.11.2023
NL01.11.2023
RS01.11.2023
SE01.11.2023
BG01.02.2024
NO01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/23]AT01.11.2023
ES01.11.2023
LT01.11.2023
NL01.11.2023
BG01.02.2024
GR02.02.2024
IS01.03.2024
PT01.03.2024
Former [2024/21]LT01.11.2023
NL01.11.2023
BG01.02.2024
GR02.02.2024
IS01.03.2024
Former [2024/20]GR02.02.2024
IS01.03.2024
Cited inInternational search[YD]US2006110429  (REIFF ANDREAS [US], et al) [YD] 1-8 * paragraph [0047] * * paragraph [0079] - paragraph [0224]; figures 1A-10C *;
 [Y]US2011054408  (WEI GUOBAO [US], et al) [Y] 7,9 * paragraph [0266] * * paragraph [0346]; figure 11 *;
 [Y]US2011159073  (DEJUAN EUGENE [US], et al) [Y] 1-3,5-9 * paragraph [0034] * * paragraph [0160]; claim 13 *;
 [Y]US2016045363  (HAFFNER DAVID S [US], et al) [Y] 1-8 * paragraph [0142] - paragraph [0155] * * paragraph [0171] * * paragraph [0175] - paragraph [0183] * * paragraph [0370] - paragraph [0437]; figures 6H-9, 13C *;
 [Y]  - LIN MAO ET AL, "Enhanced Bioactivity of Mg-Nd-Zn-Zr Alloy Achieved with Nanoscale MgF 2 Surface for Vascular Stent Application", ACS APPLIED MATERIALS & INTERFACES, US, (20150227), vol. 7, no. 9, doi:10.1021/am5086885, ISSN 1944-8244, pages 5320 - 5330, XP055530432 [Y] 1-9 * the whole document *

DOI:   http://dx.doi.org/10.1021/am5086885
 [A]  - LIN MAO ET AL, "A promising biodegradable magnesium alloy suitable for clinical vascular stent application", SCIENTIFIC REPORTS, (20170411), vol. 7, no. 1, doi:10.1038/srep46343, XP055530438 [A] 4 * the whole document *

DOI:   http://dx.doi.org/10.1038/srep46343
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.